The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 6569 -6575
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0804200

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Na, S.-Y.
Right arrow Articles by Hünig, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Na, S.-Y.
Right arrow Articles by Hünig, T.

Antigen-Specific Blockade of Lethal CD8 T-Cell Mediated Autoimmunity in a Mouse Model of Multiple Sclerosis1

Shin-Young Na*, Heike Eujen*, Kerstin Göbel{dagger}, Sven G. Meuth{dagger}, Kati Martens*, Heinz Wiendl{dagger} and Thomas Hünig2,*

* Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany; and {dagger} Department of Neurology, University of Würzburg, Würzburg, Germany

Increasing evidence implies CD8 T cells in tissue-specific autoimmune diseases including multiple sclerosis. mAbs specific for MHC class I molecules presenting a dominant autoantigenic peptide may allow selective immunotherapy in such settings. We demonstrate the prophylactic and therapeutic efficacy of such a mAb in a transgenic mouse model of lethal demyelinating disease in which a neo-self Ag expressed by oligodendrocytes is targeted by CD8 T cells with transgenic Ag receptors. Mechanistic studies performed in vitro and in vivo indicate that it is the low expression of MHC class I on oligodendrocytes, which makes this form of Ag-specific intervention possible.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Deutsche Forschungsgemeinschaft through SFB581 (to T.H. and H.W.), and Hertie foundation (to T.H.).

2 Address correspondence and reprint requests to Dr. Thomas Hünig, Institute for Virology and Immunobiology, University of Würzburg, Verbacher Straße 7, Würzburg, Germany. E-mail address: huenig{at}vim.uni-wuerzburg.de

3 Abbreviations used in this paper: MS, multiple sclerosis; TSA, tissue-specific Ag; MHC I, MHC class I; tg, transgenic; EAE, experimental autoimmune encephalomyelitis; ODC-OVA mice, mice expressing ovalbumin in oligodendrocytes; WT, wild type.

4 The online version of this article contains supplementary material.




This article has been cited by other articles:


Home page
BrainHome page
S. Bittner, S. G. Meuth, K. Gobel, N. Melzer, A. M. Herrmann, O. J. Simon, A. Weishaupt, T. Budde, D. A. Bayliss, M. Bendszus, et al.
TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system
Brain, September 1, 2009; 132(9): 2501 - 2516.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.